Heil, Joerg
Sinn, Peter
Richter, Hannah
Pfob, André
Schaefgen, Benedikt
Hennigs, André
Riedel, Fabian
Thomas, Bettina
Thill, Marc
Hahn, Markus
Blohmer, Jens-Uwe
Kuemmel, Sherko
Karsten, Maria Margarete
Reinisch, Mattea
Hackmann, John
Reimer, Toralf
Rauch, Geraldine
Golatta, Michael
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (HE 6824/5-1, funding programme Open Access Publishing, by the Baden-Württemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universität Heidelberg)
Article History
Received: 26 June 2018
Accepted: 17 August 2018
First Online: 25 August 2018
Ethics approval and consent to participate
: Before the start of the trial, the trial protocol, informed consent document, and any other appropriate documents were submitted to the independent Ethics Committee (EC). Ethical approval has been obtained for the lead investigator’s site by the Ethics Committee of the Medical Faculty Heidelberg (Reference number S-264/2016, July 13th 2016).Before being admitted to the clinical trial, all subjects must consent to participate after the nature, scope, and possible consequences of the clinical trial have been explained in a form understandable to her. Each subject must give consent in writing.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.